ASRGL1 anticorps

N° du produit ABIN7865675

Cet anticorps Souris Monoclonal détecte spécifiquement ASRGL1 dans IHC, WB et ELISA. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour ASRGL1 anticorps (ABIN7865675)

Antigène: ASRGL1 (Isoaspartyl Peptidase/L-Asparaginase (ASRGL1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp ASRGL1 est non-conjugé

Application: Immunohistochemistry (IHC), Western Blotting (WB), ELISA

Clone: 7B6

Détail du produit anti-ASRGL1 anticorps

Fonction: anti-CRASH mouse monoclonal, 7B6, purified

Purification: affinity chromatography

Immunogène: with CRASH recombinant protein and synthetic peptide

Isotype: IgG1 kappa

Information d'application

Indications d'application:

IHC-paraffin_dilution: 1:50-1:100 (1-2 μg/mL, microwave treatment in 10 mM citrate buffer pH 6.0 recommended)

WB_dilution: 1:50-1:100 (1-2 μg/mL)

IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)

elisa_dilution: assay dependent

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 100 μg/mL

Buffer: PBS with 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: store at 2 - 8 °C

Détails sur ASRGL1

Antigène: ASRGL1 (Isoaspartyl Peptidase/L-Asparaginase (ASRGL1))

Autre désignation: CRASH

Sujet: 7B6 reacts with CRASH, a 308 AA glycoprotein sharing 32 % homology with human asparaginase and identical to Asparaginase-Like Protein (ALP) found in rat sperm. CRASH is found in a variety of tumors but only occasionally in normal tissues. Especially ovarian cancers are highly positive. CRASH is further found in brain tumors, some colonic cancers, some lung cancers, some prostate cancers, uterine cancers, some breast cancers and some thyroid cancers. It was not found in serum. In Western blot 3 bands are demonstrated of 45 kDa, 28 kDa and 15 kDa. Positive control: Ovarian cancer, KM22 breast cancer cells.